Plasma levels of NO-related pathway molecules to predict post-transcatheter aortic valve implantation major adverse cardiovascular events: a prospective, multicenter study

Documenti analoghi

• Trimethylamine-N-oxide (TMAO) versus echocardiographic, biochemical and histopathological indices of heart failure in patients with severe aortic stenosis: Rationale and design of the prospective, observational TASTE study
  di: Aleksandra Gąsecka, et al.
  Pubblicazione: (2022-07-01)
• Plasma levels of NO-related pathway molecules to predict post-transcatheter aortic valve implantation major adverse cardiovascular events: a prospective, multicenter study
  di: Aleksandra Gąsecka, et al.
  Pubblicazione: (2025-06-01)
• Emergency vs. elective use of extracorporeal membrane oxygenation during transcatheter aortic valve implantation – two case reports.
  di: Radosław Wilimski, et al.
  Pubblicazione: (2025-01-01)
• Long-term mortality after transcatheter aortic valve implantation for aortic stenosis in immunosuppression-treated patients: a propensity-matched multicentre retrospective registry-based analysis
  di: Michał Walczewski, et al.
  Pubblicazione: (2023-09-01)
• Long-term neurological outcomes after transcatheter aortic valve replacement in high-volume cardiovascular care center
  di: Szymon Jonik, et al.
  Pubblicazione: (2026-11-01)